These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 564477)

  • 1. Chronic inhibition of brain protein synthesis after portacaval shunting. A possible pathogenic mechanism in chronic hepatic encephalopathy in the rat.
    Wasterlain CG; Lockwood AH; Conn M
    Neurology; 1978 Mar; 28(3):233-8. PubMed ID: 564477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain protein synthesis in rats with portacaval shunts.
    Helewski K; Konecki J
    J Physiol Pharmacol; 1994 Dec; 45(4):555-62. PubMed ID: 7727797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy.
    Vogels BA; van Steynen B; Maas MA; Jörning GG; Chamuleau RA
    J Hepatol; 1997 Feb; 26(2):387-95. PubMed ID: 9059962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portacaval shunting causes differential mitochondrial superoxide production in brain regions.
    Kosenko EA; Tikhonova LA; Alilova GA; Montoliu C; Barreto GE; Aliev G; Kaminsky YG
    Free Radic Biol Med; 2017 Dec; 113():109-118. PubMed ID: 28964916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperammonemia and chronic hepatic encephalopathy: an in vivo PMRS study of the rat brain.
    Astore D; Boicelli CA
    MAGMA; 2000 Jul; 10(3):160-6. PubMed ID: 10873206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal glutamine and ammonia metabolism during chronic hyperammonaemia induced by liver insufficiency.
    Dejong CH; Deutz NE; Soeters PB
    Gut; 1993 Aug; 34(8):1112-9. PubMed ID: 7909784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein synthesis rates in rats with portacaval shunts.
    Dunlop DS; Kaufman H; Zanchin G; Lajtha A
    J Neurochem; 1984 Nov; 43(5):1487-9. PubMed ID: 6491663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the ameliorating effects of an enteral nutrient for liver failure on hepatic encephalopathy: effects of SF-1008C on plasma and brain free amino acids, intracerebral amine concentrations and electroencephalogram in portacaval shunted rats with ammonia loading].
    Kido Y; Sugiyama K; Nakao S; Kashiyama E; Suda T; Miyamoto G; Shimizu T; Shintani S; Kohri H
    Nihon Yakurigaku Zasshi; 1986 Jul; 88(1):47-56. PubMed ID: 3093339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced clearance of proteins labeled with diisopropylfluorophosphate in portacaval-shunted rats.
    Dienel GA; Cruz NF
    Metab Brain Dis; 2014 Dec; 29(4):1041-52. PubMed ID: 24154686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portacaval shunting and hyperammonemia stimulate the uptake of L-[3H] arginine but not of L-[3H]nitroarginine into rat brain synaptosomes.
    Rao VL; Audet RM; Butterworth RF
    J Neurochem; 1997 Jan; 68(1):337-43. PubMed ID: 8978744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study.
    Rao VL; Audet RM; Butterworth RF
    J Neurochem; 1995 Sep; 65(3):1221-8. PubMed ID: 7643101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral glucose metabolism after portacaval shunting in the rat. Patterns of metabolism and implications for the pathogenesis of hepatic encephalopathy.
    Lockwood AH; Ginsberg MD; Rhoades HM; Gutierrez MT
    J Clin Invest; 1986 Jul; 78(1):86-95. PubMed ID: 3722388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy.
    Hawkins RA; Jessy J; Mans AM; De Joseph MR
    J Neurochem; 1993 Mar; 60(3):1000-6. PubMed ID: 8436955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
    Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD
    Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the metabolic disturbances caused by end-to-side and side-to-side portacaval shunts.
    Hawkins PA; DeJoseph MR; Viña JR; Hawkins RA
    J Appl Physiol (1985); 1996 Mar; 80(3):885-91. PubMed ID: 8964752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ Distribution of
    Cruz NF; Dienel GA; Patrick PA; Cooper AJL
    Neurochem Res; 2017 Jun; 42(6):1683-1696. PubMed ID: 27822667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral blood flow and metabolism in chronically hyperammonemic rats: effect of an acute ammonia challenge.
    Gjedde A; Lockwood AH; Duffy TE; Plum F
    Ann Neurol; 1978 Apr; 3(4):325-30. PubMed ID: 666274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis.
    Romero-Gomez M; Jover M; Diaz-Gomez D; de Teran LC; Rodrigo R; Camacho I; Echevarria M; Felipo V; Bautista JD
    World J Gastroenterol; 2006 Apr; 12(15):2406-11. PubMed ID: 16688834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [8. Clinical and experimental studies on the pathogenesis of portacaval encephalopathy].
    Matzander U
    Langenbecks Arch Chir; 1967; 319():81-5. PubMed ID: 5587356
    [No Abstract]   [Full Text] [Related]  

  • 20. Decrease in cerebral inositols in rats and humans.
    Moats RA; Lien YH; Filippi D; Ross BD
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):15-8. PubMed ID: 8216210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.